Journal of Antimicrobial Chemotherapy

(The median citation count of Journal of Antimicrobial Chemotherapy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-12-01 to 2023-12-01.)
ResFinder 4.0 for predictions of phenotypes from genotypes1319
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression353
Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder225
COVID-19 and the potential long-term impact on antimicrobial resistance216
Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey165
Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9143
Systematic review of mutations associated with resistance to the new and repurposedMycobacterium tuberculosisdrugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid101
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study101
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis94
The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community92
Safety of high-dose ivermectin: a systematic review and meta-analysis84
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-1984
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial83
Implications of antibiotics use during the COVID-19 pandemic: present and future79
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey78
Favipiravir, an antiviral for COVID-19?76
The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles74
Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia74
EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories72
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-1970
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study70
An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London69
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola viru66
Identification of the novel tigecycline resistance gene tet(X6) and its variants in Myroides, Acinetobacter and Proteus of food animal origin63
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomize61
A novel tigecycline resistance gene, tet(X6), on an SXT/R391 integrative and conjugative element in a Proteus genomospecies 6 isolate of retail meat origin57
Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials55
Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: a systematic review54
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study54
Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital52
Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries51
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-1951
Lopinavir pharmacokinetics in COVID-19 patients50
Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Moni46
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study45
Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrou44
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia41
The changing epidemiology of carbapenemase-producingKlebsiella pneumoniaein Italy: toward polyclonal evolution with emergence of high-risk lineages41
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect40
Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients39
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial37
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii37
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model37
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it36
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection36
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections35
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU35
Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge34
Metallo-β-lactamase resistance in Enterobacteriaceae is an artefact of currently utilized antimicrobial susceptibility testing methods34
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics33
Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes33
Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill33
Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections33
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?33
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microd33
Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model33
Characterization of a porcine Proteus cibarius strain co-harbouring tet(X6) and cfr33
Relationship of vancomycin trough levels with acute kidney injury risk: an exposure–toxicity meta-analysis31
Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters31
Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link31
Reactive oxygen species play a dominant role in all pathways of rapid quinolone-mediated killing31
When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus31
Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm31
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 201931
Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium31
Molecular mechanisms driving thein vivodevelopment of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDRPseudomonas aeruginosainfectio31
Absence of the type I-E CRISPR-Cas system in Klebsiella pneumoniae clonal complex 258 is associated with dissemination of IncF epidemic resistance plasmids in this clonal complex31
Emergence of tigecycline- and eravacycline-resistant Tet(X4)-producing Enterobacteriaceae in the gut microbiota of healthy Singaporeans30
Oxazolidinones: mechanisms of resistance and mobile genetic elements involved30
Global clonal spread of mcr-3-carrying MDR ST34 Salmonella enterica serotype Typhimurium and monophasic 1,4,[5],12:i:− variants from clinical isolates29
In vitrosusceptibility ofMycobacterium abscessuscomplex and feasibility of standardizing treatment regimens29
Can evidence-based decision support tools transform antibiotic management? A systematic review and meta-analyses29
Genomic dynamics of species and mobile genetic elements in a prolonged blaIMP-4-associated carbapenemase outbreak in an Australian hospital28
Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistantAcinetobacter baumannii(CRAb) in hospitals in Jordan28
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates28
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?28
Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases28
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinicalNeisseria gonorrhoeaeisolates from 25 European countries, 201828
High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam27
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid27
Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China27
In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China27
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim27
Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015–1627
Prevalence of antimicrobial resistance genes and its association with restricted antimicrobial use in food-producing animals: a systematic review and meta-analysis27
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa27
Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates27
Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?26
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients26
Employees of Swiss veterinary clinics colonized with epidemic clones of carbapenemase-producing Escherichia coli26
Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels26
Consumption of antibiotics in the community, European Union/European Economic Area, 1997–201726
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies26
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis25
Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli25
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile25
Do high MICs predict the outcome in invasive fusariosis?25
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection25
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia25
Dissemination of the blaCTX-M-15 gene among Enterobacteriaceae via outer membrane vesicles25
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis25
Indications for the use of highest priority critically important antimicrobials in the veterinary sector25
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-1925
High percentage of the ceftriaxone-resistantNeisseria gonorrhoeaeFC428 clone among isolates from a single hospital in Hangzhou, China25
ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi25
Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa24
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial24
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections24
Molecular epidemiology of carbapenemase-producingEscherichia colifrom duck farms in south-east coastal China24
Transferable Acinetobacter baumannii plasmid pDETAB2 encodes OXA-58 and NDM-1 and represents a new class of antibiotic resistance plasmids24
AMR-Intervene: a social–ecological framework to capture the diversity of actions to tackle antimicrobial resistance from a One Health perspective24
Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015–1624
Ganciclovir therapeutic drug monitoring in transplant recipients23
Occurrence of NDM-1-producing Morganella morganii and Proteus mirabilis in a single patient in Portugal: probable in vivo transfer by conjugation23
Emergence of a multidrug resistance efflux pump with carbapenem resistance gene blaVIM-2 in a Pseudomonas putida megaplasmid of migratory bird origin23
Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 201923
In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa23
Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria23
Molecular dynamics simulations informed by membrane lipidomics reveal the structure–interaction relationship of polymyxins with the lipid A-based outer membrane of Acinetobacter baumannii23
Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting23
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial23
Detection ofmcr-9-harbouring ESBL-producingSalmonellaNewport isolated from an outbreak in a large-animal teaching hospital in the USA23
Studies on the role of IS1216E in the formation and dissemination of poxtA-carrying plasmids in an Enterococcus faecium clade A1 isolate23
In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa22
Clinically significant drug interaction: letermovir and voriconazole22
Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany22
Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic22
Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interv22
Extensive antimicrobial resistance mobilization via multicopy plasmid encapsidation mediated by temperate phages22
Clofazimine pharmacokinetics in patients with TB: dosing implications22
On the island of Zanzibar people in the community are frequently colonized with the same MDR Enterobacterales found in poultry and retailed chicken meat22
Emergence of OXA-232-producing hypervirulent Klebsiella pneumoniae ST23 causing neonatal sepsis22
IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bactera22
A novel in silico antimicrobial peptide DP7 combats MDR Pseudomonas aeruginosa and related biofilm infections22
Antimicrobial susceptibility of Corynebacterium diphtheriae and Corynebacterium ulcerans in Germany 2011–1722
Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hos21
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012–1821
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial21
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review21
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study21
Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background21
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales21
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)21
Prevalence and genomic analysis of ESBL-producingEscherichia coliin retail raw meats in Singapore21
Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes21
Role of ppGpp-regulated efflux genes in Acinetobacter baumannii21
A novel multiresistance gene cluster located on a plasmid-borne transposon in Listeria monocytogenes21
Antibiotics and healthcare facility-associatedClostridioides difficileinfection: systematic review and meta-analysis 2020 update21
Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa21
In vitroactivity of the novel antifungal olorofim against dermatophytes and opportunistic moulds includingPenicilliumandTalaromycesspecies20
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study20
Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015–1620
Towards personalized guidelines: using machine-learning algorithms to guide antimicrobial selection20
Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)20
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy20
In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies20
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults20
A novel plasmid-borne tet(X6) variant co-existing with blaNDM-1 and blaOXA-58 in a chicken Acinetobacter baumannii isolate20
In vivopharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria20
Co-existence of tet(X4) and mcr-1 in two porcine Escherichia coli isolates20
Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology20
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening20
Novel tigecycline resistance gene cluster tnfxB3-tmexCD3-toprJ1b in Proteus spp. and Pseudomonas aeruginosa, co-existing with tet(X6) on an SXT/R391 integrative and 19
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test19
Evolution of β-lactamase-mediated cefiderocol resistance19
In vitroactivity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli fro19
Methodological features of clinical pharmacokinetic–pharmacodynamic studies of antibacterials and antifungals: a systematic review19
Characterization and outcome of invasive infections due toPaecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports19
Preliminary view of the global distribution and spread of the tet(X) family of tigecycline resistance genes19
Integration of the blaNDM-1 carbapenemase gene into a novel SXT/R391 integrative and conjugative element in Proteus vulgaris19
Characterization of AmpC-hyperproducing Escherichia coli from humans and dairy farms collected in parallel in the same geographical region19
Treating COVID-19: are we missing out the window of opportunity?19
A review of remdesivir for COVID-19 in pregnancy and lactation19
In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China19
Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK19
Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey19
Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study19
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre19
Epidemiology, clinical aspects, outcomes and prognostic factors associated with Trichosporon fungaemia: results of an international multicentre study carried out at 23 medical centres19
Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-219
The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus19
Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis19
Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy19
Class D β-lactamases18
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial18
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates18
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study18
Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and 18
Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing18
Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling18
Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A–H clinical isolates and core site-directed mutants in vitro18
Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey18
Characterization of novel ISAba1-bounded tet(X15)-bearing composite transposon Tn6866 in Acinetobacter variabilis18
In vitroactivity of rifabutin against 293 contemporary carbapenem-resistantAcinetobacter baumanniiclinical isolates and characterization of rifabutin mode of action and resistance mechan18
Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations18
Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan18
Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae18
IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis18
One Health compartmental analysis of ESBL-producing Escherichia coli on Reunion Island reveals partitioning between humans and livestock18
De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shoc17
Population pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients17
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications17
Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014–17
Neisseria gonorrhoeaeSequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antim17
Implications for IV posaconazole dosing in the era of obesity17
Activity of cefepime/zidebactam (WCK 5222) against ‘problem’ antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory17
Inherent colistin resistance in genogroups of the Enterobacter cloacae complex: epidemiological, genetic and biochemical analysis from the BSAC Resistance Surveillance Programme17
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring17
Characterization of a blaNDM-1-carrying IncHI5 plasmid from Enterobacter cloacae complex of food-producing animal origin17
Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?17
Comparison of two multiplex immunochromatographic assays for the rapid detection of major carbapenemases in Enterobacterales17
Emergence of ceftriaxone-resistant Neisseria gonorrhoeae strains harbouring a novel mosaic penA gene in China17
Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children17
Repositioning rafoxanide to treat Gram-negative bacilli infections17
Delamanid or pretomanid? A Solomonic judgement!17
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia17
Rapid detection of plasmid-mediated high-level tigecycline resistance in Escherichia coli and Acinetobacter spp16
Dalbavancin for the management of osteomyelitis: a major step forward?16
Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis16
Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain16
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP316
Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and charact16
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure16
Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy16
AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates16
Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approach16
Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study16
Microevolution of acquired colistin resistance in Enterobacteriaceae from ICU patients receiving selective decontamination of the digestive tract16
Direct detection of intact Klebsiella pneumoniae carbapenemases produced by Enterobacterales using MALDI-TOF MS16
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers16
Transmission of ESBL-producing Escherichia coli between broilers and humans on broiler farms16
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020–2116
Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time16
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control16
Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis16
Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review16
Successful rescue treatment of sepsis due to a pandrug-resistant, NDM-producing Klebsiella pneumoniae using aztreonam powder for nebulizer solution as intravenous therapy in combination with ceftazidi16
Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin16
COVID-19, antibiotics and One Health: a UK environmental risk assessment16
Impact of duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli15
Molecular genetic analysis of an XDR Pseudomonas aeruginosa ST664 clone carrying multiple conjugal plasmids15
AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics15
Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli15
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption15
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting15
Novel SCCmec type XV (7A) and two pseudo-SCCmec variants in foodborne MRSA in China15
Treatment efficacy for pharyngeal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials15
Antifungal activity of nikkomycin Z against Candida auris15
Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital15
Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases15
In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016–1815
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors15
Invasive infections withPurpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature15
EUCAST rapid antimicrobial susceptibility testing (RAST): analytical performance and impact on patient management15
Emergence and genomic characterization of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in Chengdu, China15
High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort s15
Comparative genomics of ESBL-producingEscherichia coli(ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-inte15
Role of new antibiotics for KPC-producingKlebsiella pneumoniae15
Detection in livestock of the human pandemic Escherichia coli ST131 fimH30(R) clone carrying blaCTX-M-2715
Consumption of quinolones in the community, European Union/European Economic Area, 1997–201715
A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?15
Efficacy of dalbavancin against MRSA biofilms in a rat model of orthopaedic implant-associated infection15
In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae15
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments15
Rapid spread of critical priority carbapenemase-producing pathogens in companion animals: a One Health challenge for a post-pandemic world15
Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy14
An outbreak of multiply antibiotic-resistant ST49:ST128:KL11:OCL8Acinetobacter baumanniiisolates at a Sydney hospital14
Emergence of CTX-M-27-producing Escherichia coli of ST131 and clade C1-M27 in an impacted ecosystem with international maritime traffic in South America14
Changing molecular epidemiology and characteristics of MRSA isolated from bloodstream infections: nationwide surveillance in Japan in 201914
Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care14
M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients14
Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital14
Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin14
Characterization of carbapenemase-producingSerratia marcescensand whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016–18)14
Point prevalence survey of antibiotic use in hospitals in Latin American countries14
Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study14
Population pharmacokinetics and dosing considerations of daptomycin in critically ill patients undergoing continuous renal replacement therapy14
Different phenotypic expression of KPC β-lactamase variants and challenges in their detection14
Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 201314
Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark14
Mechanisms of antibiotic resistance of Clostridioides difficile14
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis14
Assessing the effectiveness of AS-48 in experimental mice models of Chagas’ disease14
Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation14
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections14
IS26cannot move alone14
Phenotypic and genomic analysis reveals Riemerella anatipestifer as the potential reservoir of tet(X) variants14
Carbapenemase-producing Enterobacteriaceae in transplant patients14
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones13
Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization inEscherichia coli13
Efficacy and safety of sofosbuvir/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial13
Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and 13
Respiratory antibacterial prescribing in primary care and the COVID-19 pandemic in England, winter season 2020–2113
Mobile oxazolidinone/phenicol resistance gene optrA in chicken Clostridium perfringens13
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK13
Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans13
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation13
Legionellaantibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?13
VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediateStaphylococcus aureusstrain Mu5013
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings13
Identification of Proteus genomic island 2 variants in two clonal Proteus mirabilis isolates with coexistence of a novel genomic resistance island PmGRI113
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa13
Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods13
Remdesivir and GS-441524 plasma concentrations in patients with end-stage renal disease on haemodialysis13
Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins13
Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo13
Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, France13
Optical maps of plasmids as a proxy for clonal spread of MDR bacteria: a case study of an outbreak in a rural Ethiopian hospital13
A nationwide genomic study of clinical Klebsiella pneumoniae in Norway 2001–15: introduction and spread of ESBLs facilitated by clonal groups CG15 and CG30713
Reorganization of mcr-1-bearing large MDR plasmids resolved by nanopore sequencing13
Prevalence and molecular epidemiology of mcr-1-positive Klebsiella pneumoniae in healthy adults from China13
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV13
In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii13
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients13
Structural and mechanistic analysis of ATPase inhibitors targeting mycobacterial DNA gyrase13
When to change treatment of acute invasive aspergillosis: an expert viewpoint13
Emergence of livestock-associated MRSA ST398 from bulk tank milk, China13
Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tube13
An updated phylogeny of the metallo-β-lactamases13
Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 202213
Efficacy and safety of colistin loading dose: a meta-analysis13
Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon13
Rapid detection and characterization of tet(X4)-positive Escherichia coli strains with nanopore sequencing12
Discovery and characterization of New Delhi metallo-β-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae12
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations12
Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment12
A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva12
Characterization of Acinetobacter indicus co-harbouring tet(X3) and blaNDM-1 of dairy cow origin12
Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections12
Antimicrobial stewardship programmes in nursing homes: a systematic review and inventory of tools12
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study12
The association of remdesivir and in-hospital outcomes for COVID-19 patients treated with steroids12
Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity12
Implementation of rapid antimicrobial susceptibility testing combined with routine infectious disease bedside consultation in clinical practice (RAST-ID): a prospective single-centre study12
Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals12
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen12
SARS-CoV-2 coinfection with additional respiratory virus does not predict severe disease: a retrospective cohort study12
Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals12
A genome-wide analysis of Escherichia coli responses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate degradation and phosphate transport systems12
Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) β-lactamase enzymes inAcinetobacter baumannii12
HIV MDR is still a relevant issue despite its dramatic drop over the years12
The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections12
Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales12
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam inPseudomonas aeruginosaisolates recovered from ICU patients in Spain and Portugal depicted by WGS12
Prediction of dolutegravir pharmacokinetics and dose optimization in neonates via physiologically based pharmacokinetic (PBPK) modelling12
Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): activity of ceftazidime/avibactam against Enterobacterales isolated from urine12
The paradoxical in vivo activity of β-lactams against metallo-β-lactamase-producing Enterobacterales is not restricted to carbapenems12
Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France12
Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-1912
Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study12
Azithromycin in patients with COVID-19: a systematic review and meta-analysis12
Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis12
Methionyl-tRNA synthetase inhibitor has potent in vivo activity in a novel Giardia lamblia luciferase murine infection model12
The bla and mec families of β-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococ12
Antimicrobial activity of honey in periodontal disease: a systematic review12
Thiocillin and micrococcin exploit the ferrioxamine receptor of Pseudomonas aeruginosa for uptake12
Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance12
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae12
The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis12
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation12
What are the most effective community-based antimicrobial stewardship interventions in low- and middle-income countries? A narrative review12
Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015–19)12
Genetic features of the poxtA linezolid resistance gene in human enterococci from France12
Stigmasterol as a potential biomarker for amphotericin B resistance in Leishmania donovani11
Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional surv11
Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance11
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 201911
Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carb11
Plasmids of novel incompatibility group IncpRBL16 from Pseudomonas species11
Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region11
Antibiotics targeting bacterial ribosomal subunit biogenesis11
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations11
A whole-genome screen identifies Salmonella enterica serovar Typhi genes involved in fluoroquinolone susceptibility11
A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry11
Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolate11
Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata11
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV11
CpxR regulates the colistin susceptibility of Salmonella Typhimurium by a multitarget mechanism11
Cefepime-induced neurotoxicity: systematic review11
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients11
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones11
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients11
Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs11
Management of posaconazole-induced pseudohyperaldosteronism11
Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance11
Interchangeability of periplasmic adaptor proteins AcrA and AcrE in forming functional efflux pumps with AcrD in Salmonella enterica serovar Typhimurium11
In vitro activity of ceftazidime/avibactam and comparators against Gram-negative bacterial isolates collected from Latin American centres between 2015 and 201711
Salmonella enterica serovar Typhi H58 clone has been endemic in Zimbabwe from 2012 to 201911
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations11
Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load11
Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria11
Characteristics of fosA-carrying plasmids in E. coli and Klebsiella spp. isolates originating from food and environmental samples11
Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study11
Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation11
Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales11
Role of glyphosate in the emergence of antimicrobial resistance in bacteria?11
Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision11
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015–1811
Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveil11
Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes11
Genomic background of the Klebsiella pneumoniae NDM-1 outbreak in Poland, 2012–1811
A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK11
How did a Quality Premium financial incentive influence antibiotic prescribing in primary care? Views of Clinical Commissioning Group and general practice professionals11
Aztreonam/avibactam effect on pharmacodynamic indices for mutant selection ofEscherichia coli and Klebsiella pneumoniaeharbouring serine- and New Delhi metallo-β-lactamases11
Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package10
Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials10
SC5005 dissipates the membrane potential to kill Staphylococcus aureus persisters without detectable resistance10
Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA10
Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring blaKPC variants associated with ceftazidime/avibactam resistance10
Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study10
Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim10
Evaluation of a diagnostic algorithm for rapid identification of Gram-negative species and detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures10
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing10
Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB)10
Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV10
Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997–201710
Consumption of penicillins in the community, European Union/European Economic Area, 1997–201710
Efficacy of continuous versus intermittent administration of nanoformulated benznidazole during the chronic phase of Trypanosoma cruzi Nicaragua infection in mice10
RNA markers for ultra-rapid molecular antimicrobial susceptibility testing in fluoroquinolone-treated Klebsiella pneumoniae10
Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: a rando10
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir10
Transmission potential of paromomycin-resistant Leishmania infantum and Leishmania donovani10
Do antibiotics cause mitochondrial and immune cell dysfunction? A literature review10
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo10
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)10
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections—authors’ response10
Impact of pre-existing drug resistance on risk of virological failure in South Africa10
A nationwide parent survey of antibiotic use in Australian children10
Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement10
Oral fosfomycin use for pyelonephritis and complicated urinary tract infections: a 1 year review of outcomes and prescribing habits in a large municipal healthcare system10
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales10
In vitro activity of 20 antibiotics against Cupriavidus clinical strains10
Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study10
Identification of a novel tetracycline resistance gene, tet(63), located on a multiresistance plasmid from Staphylococcus aureus10
Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes10
Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study10
Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent-stage survival assay (QSA)10
A historical perspective of MDR invasive pneumococcal disease in Spanish adults10
Quality appraisal of antibiotic consumption in the community, European Union/European Economic Area, 2009 and 201710
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled stu10
Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom10
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-1910
β-Lactam antimicrobial  pharmacokinetics and target attainment in critically ill patients aged 1 day to 90 years: the ABDose study10
Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study10
Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy10
Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus10
In vitroantibiotic activity against intraosteoblasticStaphylococcus aureus: a narrative review of the literature10
Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania10
The use of theory in the development and evaluation of behaviour change interventions to improve antimicrobial prescribing: a systematic review10
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae10
External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy10
Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans10
A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method10
Emergence of a Salmonella enterica serovar Typhimurium ST34 isolate, CFSA629, carrying a novel mcr-1.19 variant cultured from egg in China10
Antibacterial efficacy of R-type pyocins against Pseudomonas aeruginosa on biofilms and in a murine model of acute lung infection10
Pretreatment HIV drug resistance spread within transmission clusters in Mexico City10
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda10
Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing Enterobacterales10
Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact9
Identification of a novel optrA-harbouring transposon, Tn6823, in Staphylococcus aureus9
A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa9
Redefining therapeutic success in HIV patients: an expert view9
Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance9
Dissemination of NDM-producingKlebsiella pneumoniaeandEscherichia colihigh-risk clones in Catalan healthcare institutions9
In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence9
Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib9
Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997–20179
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model9
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial9
Evaluation of effectiveness and compliance with the mupirocin nasal ointment part of Staphylococcus aureus decolonization in real life using UPLC-MS/MS mupirocin quantification9
Emergence of VIM-producing Enterobacter cloacae complex in France between 2015 and 20189
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations9
Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis9
A multicentre outbreak of ST45 MRSA containing deletions in the spa gene in New South Wales, Australia9
Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 9
Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain9
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat admini9
A combined assay for quantifying remdesivir and its metabolite, along with dexamethasone, in serum9
EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence9
Clinical exposure–response relationship of cefepime/taniborbactam against Gram-negative organisms in the murine complicated urinary tract infection model9
Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region9
Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level 9
Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints9
Evaluation of the SpeeDxResistancePlus®GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin inNeisser9
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights9
A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa9
Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa cli9
Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates9
Co-existence of plasmid-mediated tigecycline and colistin resistance genes tet(X4) and mcr-1 in a community-acquired Escherichia coli isolate in China9
Whole-genome analysis of the potentially zoonotic Elizabethkingia miricola FL160902 with two new chromosomal MBL gene variants9
Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China9
AmpR ofStenotrophomonas maltophiliais involved in stenobactin synthesis and enhanced β-lactam resistance in an iron-depleted condition9
Evaluation of a fully automated bioinformatics tool to predict antibiotic resistance from MRSA genomes9
Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals9
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting9
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients9
Prevalence and risks factors associated with ESBL-producing faecal carriage in a single long-term-care facility in Spain: emergence of CTX-M-24- and CTX-M-27-producing Escherichia coli ST131-H30R9
In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases9
White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net n9
European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 20189